Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

Returns on capital

Avalyn Pharma Inc. Common Stock management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

No return metrics data available.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Lyn Baranowski

CEO, President & DirectorUSD 804.5K50——

Howard Lazarus

Chief Medical OfficerUSD 667.45K60——

Douglas R. Carlson

CFO & Chief Business OfficerUSD 656K47——

Melissa Rhodes DABT

Chief Operating OfficerUSD 635.2K48——

Jill Denning

Senior Vice President of Clinical Development Operations————

Craig Conoscenti

Senior Vice President of Clinical Development————

Stephen Pham

Senior Vice President of Product Development————

Adam Golden

General Counsel & Head of Business Development—62——

James Bishop

Senior Vice President of Business Operations————

Cassie Saitow

Senior Director of IR & Corporate Communications————

Michelle Patterson

Senior Vice President of Corporate Planning & Portfolio Strategy————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

4

$6.70M

Net Transaction Value

−$6.70M

Net selling

Most Active

FMR LLC

4 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 10, 26

FMR LLC

Indirect

Sell$164.5K
Nov 10, 26

FMR LLC

Indirect

Sell$1.5M
Nov 9, 26

FMR LLC

Indirect

Sell$5M
Nov 9, 26

FMR LLC

Indirect

Sell$39.8K

Summary

Insiders reported 0 buys worth $0.00 and 4 sells worth $6.70M over the last 12 months. That adds up to net selling of $6.70M. FMR LLC was the most active insider with 4 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

No growth data available

Competitors

Who does Avalyn Pharma Inc. Common Stock compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about AVLN's management, answered from reported figures.

Who manages AVLN?

Avalyn Pharma Inc. Common Stock (AVLN) lists 11 active executives. The top listed executive is Jill Denning, Senior Vice President of Clinical Development Operations.

Are AVLN insiders buying or selling?

Recent insider activity shows net selling of $5.63M.